uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences.
Show others and affiliations
2001 In: Eur J Cancer, Vol. 37, no 2, 260-67 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2001. Vol. 37, no 2, 260-67 p.
URN: urn:nbn:se:uu:diva-89532OAI: oai:DiVA.org:uu-89532DiVA: diva2:161082
Available from: 2001-11-01 Created: 2001-11-01Bibliographically approved
In thesis
1. Pharmacological Studies of CHS 828 and Etoposide Induced Tumour Cell Death
Open this publication in new window or tab >>Pharmacological Studies of CHS 828 and Etoposide Induced Tumour Cell Death
2001 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Antitumour properties of the cyanoguanidine CHS 828 and analogues were discovered in 1997. CHS 828 is presently in clinical phase I/II trials. This thesis encompasses in vitro studies of the kinetics and mode of cell death induced in the human cell line U-937 GTB, by CHS 828 and the standard antitumour drug etoposide.

Etoposide induces apoptosis in U-937 GTB within 4 h. The cells exhibited apoptotic morphology, including condensed and fragmented nuclei and formation of apoptotic bodies, activation of caspase 3 and 8, and DNA fragmentation, visualised by TdT-mediated dUTP nick end-labelling (TUNEL).

CHS 828 induced few and weak signs of apoptosis. Metabolic activity was the only parameter affected during the first 24 h of exposure. After ~30 h, proliferation (DNA synthesis) and protein synthesis ceased, and viability started to decrease towards 10% at 72 h. Morphology and ultrastructure of dying/dead cells showed predominant necrosis. The decrease in viability was postponed by protein synthesis inhibition or maintenance of ATP levels by 3-aminobenzamide. In addition, 3-aminobenzamide switched morphology towards apoptosis.

Continuous co-exposure to CHS 828 and etoposide resulted in impressive cell kill synergy in U-937 GTB cells at effect levels of 30-70%. Pre-exposure to CHS 828 for 18 h or more, on the other hand, resulted in diminished cell kill and inability to activate the apoptotic machinery upon etoposide stimulation, evaluated by morphology and caspase activity.

In summary, CHS 828 induced cell death is predominantly non-apoptotic, does not involve caspases and can be postponed by maintained protein synthesis and ATP levels.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2001. 53 p.
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 0282-7476 ; 1095
Medical sciences, Cancer chemotherapy, cell death, caspase, etoposide, CHS 828, MEDICIN OCH VÅRD
National Category
Medical and Health Sciences
Research subject
Clinical Pharmacology
urn:nbn:se:uu:diva-1500 (URN)91-554-5157-8 (ISBN)
Public defence
2001-11-24, Auditorium Minus, Gustavianum, Uppsala, 09:15
Available from: 2001-11-01 Created: 2001-11-01Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 35 hits
ReferencesLink to record
Permanent link

Direct link